JANSSEN CILAG FARMACEUTICA, LDA. secures contract for 1783/2025 - Invitation To Submit A Proposal By Direct Award For The Acquisition Of B466 - Bosentano [32 Mg; Comp Disp], And B925 - Bedaquiline [100 Mg; Cap/Comp] To Meet The Needs Of Entities

Portugal, Oct. 31 -- Portugal based JANSSEN CILAG FARMACEUTICA, LDA. has secured contract from Unidade Local De Saude De Lisboa Ocidental, E. P. E. for 1783/2025 - Invitation To Submit A Proposal By Direct Award For The Acquisition Of B466 - Bosentano [32 Mg; Comp Disp], And B925 - Bedaquiline [100 Mg; Cap/Comp] To Meet The Needs Of Entities. The value of the contract is worth 2216232 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....